K Wright

1.6k total citations · 1 hit paper
10 papers, 1.3k citations indexed

About

K Wright is a scholar working on Molecular Biology, Oncology and Pathology and Forensic Medicine. According to data from OpenAlex, K Wright has authored 10 papers receiving a total of 1.3k indexed citations (citations by other indexed papers that have themselves been cited), including 4 papers in Molecular Biology, 4 papers in Oncology and 3 papers in Pathology and Forensic Medicine. Recurrent topics in K Wright's work include RNA modifications and cancer (3 papers), Genetic factors in colorectal cancer (2 papers) and Cancer-related Molecular Pathways (2 papers). K Wright is often cited by papers focused on RNA modifications and cancer (3 papers), Genetic factors in colorectal cancer (2 papers) and Cancer-related Molecular Pathways (2 papers). K Wright collaborates with scholars based in Australia, United States and United Kingdom. K Wright's co-authors include Thomas J. Schall, Maureen Howard, Mary Jean Sunshine, Kevin Wei, Yu Wang, Dan R. Littman, Calvin J. Kuo, Jennifer M. Burns, Anita Melikian and Zhenhua Miao and has published in prestigious journals such as Science, The Journal of Experimental Medicine and Gastroenterology.

In The Last Decade

K Wright

10 papers receiving 1.3k citations

Hit Papers

A novel chemokine receptor for SDF-1 and I-TAC involved i... 2006 2026 2012 2019 2006 250 500 750 1000

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
K Wright Australia 8 885 664 449 118 95 10 1.3k
Linhua Zou United States 8 1.3k 1.4× 2.0k 3.0× 390 0.9× 62 0.5× 159 1.7× 10 2.5k
Simona Infantino Australia 10 795 0.9× 739 1.1× 382 0.9× 100 0.8× 55 0.6× 14 1.2k
Elena Tassi Italy 16 646 0.7× 547 0.8× 554 1.2× 76 0.6× 90 0.9× 24 1.4k
Konstantin Knoblich United States 15 509 0.6× 708 1.1× 447 1.0× 154 1.3× 113 1.2× 19 1.4k
Catherina L. Salanga United States 16 561 0.6× 490 0.7× 588 1.3× 115 1.0× 48 0.5× 19 1.2k
Frédéric van den Brûle Belgium 12 415 0.5× 628 0.9× 784 1.7× 104 0.9× 212 2.2× 15 1.3k
Helena Kiefel Germany 17 341 0.4× 253 0.4× 605 1.3× 120 1.0× 257 2.7× 23 1.2k
Bernd Algermissen Germany 14 240 0.3× 457 0.7× 262 0.6× 163 1.4× 77 0.8× 26 956
Eleni Maniati United Kingdom 19 750 0.8× 708 1.1× 580 1.3× 128 1.1× 272 2.9× 40 1.6k
Susanna Lewén United States 10 560 0.6× 544 0.8× 231 0.5× 59 0.5× 59 0.6× 12 886

Countries citing papers authored by K Wright

Since Specialization
Citations

This map shows the geographic impact of K Wright's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by K Wright with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites K Wright more than expected).

Fields of papers citing papers by K Wright

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by K Wright. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by K Wright. The network helps show where K Wright may publish in the future.

Co-authorship network of co-authors of K Wright

This figure shows the co-authorship network connecting the top 25 collaborators of K Wright. A scholar is included among the top collaborators of K Wright based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with K Wright. K Wright is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

10 of 10 papers shown
1.
Farrar, Mark D., Richard White, K Wright, et al.. (2011). Topical aminolaevulinic acid-photodynamic therapy produces an inflammatory infiltrate but reduces Langerhans cells in healthy human skin in vivo. British Journal of Dermatology. 165(3). 513–519. 20 indexed citations
2.
Keshav, Satish, et al.. (2007). Ccx282-B, an orally active inhibitor of chemokine receptor Ccr9, shows anti-inflammatory & clinical activity in the treatment of Crohn's disease. Gastroenterology. 132. 13 indexed citations
3.
Velde, Anje A. te, L. Pronk, Satish Keshav, et al.. (2007). Traficet-EN (CCX282-B), an orally active inhibitor of chemokine receptor CCR9, for treatment of Crohnʼs disease. Inflammatory Bowel Diseases. 13. 647–647. 2 indexed citations
4.
Burns, Jennifer M., Yu Wang, Anita Melikian, et al.. (2006). A novel chemokine receptor for SDF-1 and I-TAC involved in cell survival, cell adhesion, and tumor development. The Journal of Experimental Medicine. 203(9). 2201–2213. 1048 indexed citations breakdown →
5.
McGlinn, Edwina, Anna Marsh, Timothy A. Evans, et al.. (2000). Sequence variants of DLC1 in colorectal ovarian tumours. Human Mutation. 15(2). 156–165. 13 indexed citations
6.
Wilson, Peter J., Edwina McGlinn, Anna Marsh, et al.. (2000). Sequence variants ofDLC1 in colorectal and ovarian tumours. Human Mutation. 15(2). 156–165. 31 indexed citations
7.
Wright, K, Peter J. Wilson, Sarah J. Morland, et al.. (1999). ?-Catenin mutation and expression analysis in ovarian cancer: Exon 3 mutations and nuclear translocation in 16% of endometrioid tumours. International Journal of Cancer. 82(5). 625–629. 111 indexed citations
8.
Imyanitov, Evgeny N., Geoffrey W. Birrell, I V Filippovich, et al.. (1999). Frequent loss of heterozygosity at 1p36 in ovarian adenocarcinomas but the gene encoding p73 is unlikely to be the target. Oncogene. 18(32). 4640–4642. 30 indexed citations
9.
Wright, K, Peter J. Wilson, J. F. R. Kerr, et al.. (1998). Frequent loss of heterozygosity and three critical regions on the short arm of chromosome 8 in ovarian adenocarcinomas. Oncogene. 17(9). 1185–1188. 59 indexed citations
10.
Wright, K. (1990). Breast Cancer: Two Steps Closer to Understanding. Science. 250(4988). 1659–1659. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026